# IMATINIB MESYLATE
> **ANDA208302** · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA · Approved 2019-01-17
## Drug
- **FDA Application Number:** ANDA208302
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IMATINIB MESYLATE
- **Generic name:** IMATINIB MESYLATE
- **Active ingredients:** IMATINIB MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SHILPA
- **Manufacturer:** Ascend Laboratories, LLC
- **First approval:** 2019-01-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208302)
---
*AI Analytics · CC0 1.0*